Vascular endothelial growth factor

Journal of Neuro-Oncology

Volumn 35, Issue 3, 1997, Pages 365-372

  Plate, Karl H ^a,b   Warnke, Peter C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Edema; Endothelium; Vascular permeability; VEGF; VEGF receptors

Indexed keywords

GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BRAIN TUMOR; EDEMA; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD VESSELS; BRAIN NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030772252     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Ferrara N, Henzel WL: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm 161:851-858, 1989
2. Plouët J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AT-20 cells. EMBO J 8: 3801-3806, 1989
3. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells. Proc Natl Acad Sci USA 86: 7311-7315, 1989
4. Conn G, Sodermann DD, Schaeffer M-T, Wile M, Hatcher VB, ThomPurification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87: 1323-1327, 1990
5. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 26031-26037, 1991
6. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13: 18-32, 1992
7. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrin 5: 1806-1814, 1991
8. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
9. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992
10. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037, 1992
11. Park JE, Keller GA, Ferrara N: Vascular endothelial growth factor (VEGF) isoforms - differential deposition into the subepithelial extracellular-matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326, 1993
12. 165 and PDGF-BB. Anat Embryol 186: 251-257, 1992
13. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu L-Q, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis. J Clin Invest 93: 662-670, 1994
14. Bär T: The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol 59: 1-62, 1980
15. Risau W: Vasculogenesis, angiogenesis and endothelial cell differentiation during embryonic development. In: Feinberg RN, Sherer KG, Auerbach R (eds) The development of the vascular system, pp. 58-68. Basel: S. Karger AG, 1991
16. Senger D, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, D vorak HF: Tumor cells secrete a vascular permeability factor which promotes ascites fluid accumulation. Science 219: 983-985, 1983
17. Senger D, Peruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res 46: 5629-, 1986
18. Bruce JN, Criscuolo GR, Merril MJ et al.: Vascular permeability induced by protein product of malignant brain tumors: inhibition of dexamethason. J Neurosurg 67: 880-884, 1987
19. Criscuolo GR, Merril MJ, Oldfield EH: Further characterization of a malignant-glioma-derived vascular permeability factor. J Neurosurg 69: 254-262, 1988
20. Keck P, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Conolly DT: Vascular permeability factor, an endothelial cell specific mitogen related to PDGF. Science 146: 1309-1312, 1989
21. Senger DR, Conolly DT, Van De Water L, Feder J, Dvorak HF: Purification and NH2-terminal amino acid sequence of guinea-pig tumor-secreted vascular permeability factor. Cancer Res 50: 1774-1778, 1990
22. Connolly DT: Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 47: 219-223, 1991
23. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM: Ultrastructural localization of vascular permeability factor (VPF/VEGF) to the abluminal plasma membrane and vesicuolo-vascular organelles of tumor microvascular endothelium. J Histochem Cytochem 43: 381-389, 1995
24. Roberts WG, Palade GE: Increased microvascular permeability and endothelial fenestration by vascular endothelial growth factor. J Cell Science 108: 2369-2379, 1995
25. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van De Water L, Senger D, Dvorak HF, Hosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney International 42: 1457-1461, 1992
26. Simon M, Gröne H-J, Jöhren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268: F240-250, 1995
27. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushima H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 5: 519-524, 1990
28. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
29. Peters KG, de Vries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919, 1993
30. Breier G, Clauss M, Risau W: Coordinate expression of VEGF-receptor 1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dynamics 204: 228-239, 1995
31. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992
32. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53: 5822-5827, 1993
33. Plate KH, Breier G, Weich HA, Mennel HD, Risau W: Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529, 1994
34. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M: A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Fit tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9: 2683-2690, 1994
35. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH: Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995, 1994
36. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from fit tyrosine kinase, a receptor for vascular endothelial growth factor. Oncogene 10: 135-147, 1995
37. Fong G-H, Rossant J, Gertsenstein M, Breitman ML: Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70, 1995
38. Eichmann A, Marcelle C, Bréant C, Le Douarin NM: Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mech Dev 42: 33-48, 1993
39. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J : flk-1, an flt-1 related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489-498, 1993
40. Terman BC, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Comm 187: 1579-1586, 1992
41. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Möller NP, Risau W, Ullrich A : High affinity VEGFbinding and developmental expression suggests Flk-1 as a major regulator of angiogenesis and vasculogenesis. Cell 72: 835-846, 1993
42. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in flk-1 deficient mice. Nature 376: 62-66, 1995
43. Plate KH, Mennel HD: Vascular morphology and angiogenesis in glial tumors. Exp Toxic Pathol 47: 89-94, 1995
44. Plate KH, Risau W: Angiogenesis in malignant gliomas. Glia 15: 339-347, 1995
45. Brem S, Cotran R, Folkman J : Tumor angiogenesis: a quantitative method for histological grading. J Natl Cancer Inst 48: 347-356, 1972
46. Groothuis DR, Vrieserdorp FJ, Kupfer B, Warnke PC, Lapin GD, Kuruvilla A, Viek NA, Mikhael MA, Patlak CS: Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol 30: 581-588, 1991
47. Warnke PC, Hans FJ, Korst A, Mall C, Ostertag CB: Simultaneous measurement of bidirectional capillary permeability, vascular volume, extracellular space and rCBF in experimental gliomas and surrounding edema. Acta Neurochir 60: 341-343, 1994
48. Warnke PC, Molnar P, Lapin GD, Kuruvilla A, Groothuis DR: The effects of dexamethasone on transcapillary transport in experimental brain tumors: II. Canine brain tumors. J Neuro-Oncol 25: 29-38, 1995
49. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathology 4: 207-218, 1994
50. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van de Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 174: 1275-1278, 1991
51. Tessler S, Rockwell P, Hicklin D, Cohen T, Levi BZ, Witte L, Lemischka IR, Neufeld G: Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 269: 12456-12461, 1994
52. Terman BI, Khandke L, Doughervermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M: VEGF receptor subtypes KDR and Flt-1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11: 187-195, 1994
53. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189-1193, 1995
54. Strugar J, Rothbart D, Harrington W, Criscuolo GR: Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81: 560-566, 1994
55. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
56. Minchenko A, Bauer T, Salceda S, Caro J: Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374-379, 1994
57. Goldberg MA, Schneider J: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth-factor and erythropoietin. J Biol Chem 269: 4355-4359, 1994
58. Minchenko A, Salceda S, Bauer T, Caro J: Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40: 35-39, 1994
59. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced activation and increased mRNA stability of vascular endothelial growth factor (VEGF) in C6 glioma cells. J Biol Chem 270: 19761-19766, 1995
60. Mukhopadhyay D, Tslokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-580, 1995
61. Phillips HS, Armani MP, Stavrou D, Ferrara N, Westphal M: Intense local expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis. Int J Oncol 2: 913-919, 1993
62. Russel DS, Rubinstein LJ: Pathology of tumours of the nervous system. London, Edward Arnold, 1989
63. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids - implications for tumor angiogenesis. Proc Natl Acad Sci USA 92: 768-772, 1995
64. Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4: 121-133, 1993
65. Tsai J-C, Goldman CK, Gillespie Y: Vascular endothelial-growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82: 864-873, 1995
66. Kieser A, Weich HA, Brandner G, Marmé D, Kölch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994
67. Weindel K, Moringlane JR, Marmé D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid. Neurosurg 35: 439-449, 1994
68. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153-159, 1993
69. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R: Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Comm 194: 749-755, 1993
70. Wizigmann-Voos S, Breier G, Risau W, Plate KH: Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau-disease associated and in sporadic hemangioblastomas. Cancer Res 55: 1358-1364, 1995
71. Kanno H, Kondo K, Ito S, Yamamoto I, Fuji S, Soichiro T, Sasaki N, Hosaka M, Shuin T, Yao M: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemanglioblastomas. Cancer Res 54: 4845-4847, 1994
72. Oelrichs RB, Reid HH, Bernard O, Ziemiecki A, Wilks AF: NYK/FLK-1: a putative receptor tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 8: 11-18, 1993
73. Millauer B, Shawver L, Plate KH, Risau W, Ullrich A : Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579, 1994
74. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM: Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56: 1615-1620, 1996
75. Kim JB, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993